https://www.selleckchem.com/products/U0126.html
Furthermore, CD5 was positively correlated with CD6 in TCM patients. Compared with patients who were CD5 CD6 , T-ALL and TCL patients who were CD5 CD6 had poor OS. Importantly, CD5 CD6 was an independent prognostic predictor for OS in T-ALL (HR = 0.39, 95% CI 0.23-0.65, 0.001) and TCL (HR = 0.35, 95% CI 0.19-0.62, 0.001) patients. Low expression of CD5 and CD6 was associated with poor OS for TCM patients, and this may be a potential immune biomarker panel for prognostic stratification of TCM patients. Low expression of CD5 and C